Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT01171911

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01171911
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01171911. Randomized; single masking; primary purpose treatment. Start 2010-10 (registry gives no type); primary completion 2010-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Comparison of Intravenous Injection of Calcium Antagonist and Beta-blockade on Endothelial Shear Stress of Coronary Artery
Condition
Acute Coronary Syndrome
Intervention (Drug)
Nicardipine , Esmolol
Lead sponsor
Nanjing Medical University (class: other)

Record details

Record id
cardio:ct-nct01171911
Content hash
ecd82a17176641697d93fdf89846abbf8b0ecd100d862618d44d6c850698d20a